Eli Lilly and Co. Inc. has acquired two experimental products under development for use in diagnosing Alzheimer's, and put its Philadelphia subsidiary in charge of further developing and validating them.
http://www.bizjournals.com/philadelphia/news/2013/04/17/avid-to-work-on-alzheimers-traces.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_33+%28Health+Insurance+Industry+News%29
http://www.bizjournals.com/philadelphia/news/2013/04/17/avid-to-work-on-alzheimers-traces.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_33+%28Health+Insurance+Industry+News%29
No comments:
Post a Comment